FDA — authorised 19 March 1963
- Marketing authorisation holder: AQUA PHARMS
- Status: approved
🇺🇸 Cordran in United States
FDA authorised Cordran on 19 March 1963
Marketing authorisations
FDA — authorised 19 March 1963
- Application: NDA013790
- Marketing authorisation holder: INA PHARMS
- Local brand name: CORDRAN
- Indication: LOTION — TOPICAL
- Status: approved
FDA — authorised 18 October 1965
- Application: NDA012806
- Marketing authorisation holder: INA PHARMS
- Local brand name: CORDRAN
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 29 July 1969
- Application: NDA016455
- Marketing authorisation holder: ALMIRALL
- Local brand name: CORDRAN
- Indication: TAPE — TOPICAL
- Status: approved
Cordran in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Cordran approved in United States?
Yes. FDA authorised it on 19 March 1963; FDA authorised it on 19 March 1963; FDA authorised it on 18 October 1965.
Who is the marketing authorisation holder for Cordran in United States?
AQUA PHARMS holds the US marketing authorisation.